N/A
N=83
Technology Interventions to Improve Outcomes After Knee Replacement
Knee Arthroplasty
Bottom Line
View on ClinicalTrials.gov: NCT04482400 ↗Enrolled (actual)
83
Serious AEs
3.6%
Results posted
Mar 2026
Primary outcome: Primary: Objectively Measured (Actigraph) Sedentary Behavior at 2 Months — 659.52; 638.24 minutes/day
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- NEAT!2 (Behavioral); MyKneeGuide (Behavioral)
- Age
- Adult, Older Adult · 40+ yrs
- Sex
- All
- Sponsor
- University of South Carolina
- Primary completion
- Oct 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Objectively Measured (Actigraph) Sedentary Behavior at 2 Months |
659.52; 638.24 | — |
| PRIMARY Objectively Measured (Actigraph) Sedentary Behavior at 5 Months |
674.17; 638.62 | — |
| SECONDARY Physical Function |
1338.67; 1340.04 | — |
| SECONDARY WOMAC Pain Subscale |
3.05; 3.0 | — |
| SECONDARY Total Physical Activity Measured by Actigraph Accelerometers |
1532.41; 1442.08 | — |
| SECONDARY Adherence to Calls |
4.8; 4.8 | — |
| SECONDARY Adherence to NEAT!2 App |
40.3 | — |
| SECONDARY Response to NEAT!2 Prompts |
9.7 | — |
| SECONDARY Physical Function Via Chair Stand Test |
10.59; 10.39 | — |
Summary
The purpose of this study is to examine the effects of two technology interventions on health outcomes (e.g., physical activity, sedentary behavior, physical function, pain) after knee replacement at 2 and 5 months .
Eligibility Criteria
Inclusion Criteria
- Be 40-79 years of age
- Had unilateral knee replacement within last 12 months
- Have an Android or iOS smartphone that is accessible and near them the majority of the day
- Be willing to download the study applications on their smartphone
- Spend at least 7 hours/day sitting
- Be English speaking
Exclusion Criteria
- Have any contraindications to activity
- Have a mobility limiting comorbidity
- Have a scheduled surgery within the next 6 months
- Do not have ≥4 days of valid accelerometer (>=10 hours) wear at baseline.
Data sourced from ClinicalTrials.gov (NCT04482400). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.